Cytokinetics, Incorporated (CYTK)
NMS – Real Time Price. Currency in USD
76.52
+0.07 (0.09%)
Market open: Aug 12, 2026, 10:43 AM EDT
76.67
+0.22 (0.29%)
Previous after-hours: Aug 11, 2026, 7:35 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
76.52
+0.07 (0.09%)
Market open: Aug 12, 2026, 10:43 AM EDT
76.67
+0.22 (0.29%)
Previous after-hours: Aug 11, 2026, 7:35 PM EDT
No Data
There are no news for this stock.
Total debt $1.3B significantly exceeds cash reserves ($258.4M), raising financial stability concerns
Total current assets $1.2B exceed Total current liabilities $181.4M, highlighting excellent liquidity
Debt-to-equity ratio (-7.3) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-5.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$164.2M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.66 | 6.05 | 10 | |
| Quick ratio | 6.66 | 5.63 | 10 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.66 | 1.04 | 3.0 | |
| Interest coverage | -5.14 | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 95M | 8M | 18M | 88M | 68M |
| Gross Profit | 86M | -4M | 9M | 78M | 47M |
| Operating Income | -324M | -496M | -536M | -612M | -708M |
| Net Income | -389M | -526M | -590M | -785M | -894M |
| EBITDA | -316M | -484M | -527M | -602M | -695M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 1720.93 | 42.42 | 10 |
| Next quarter | 197.35 | 4.39 | 7.0 |
| Current year | 57.64 | 6.89 | 7.5 |
| Next year | 202.35 | 26.94 | 10 |
| Weighted average score | 8.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 47.89 | 3.53 | 10.18 | -8.44 | 5.5 |
| Y/Y | -57.12 | -47.91 | -33.92 | -24.01 | 1.0 |
| 3y average | 143.29 | -26.81 | -15.55 | -21.21 | 3.3 |
| 5y average | 98.06 | -46.04 | -28.68 | -1820.22 | 3.3 |
| Weighted average score | 3.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 2.2 | |